Journey Medical (DERM) EBT (2020 - 2026)

Journey Medical (DERM) has reported EBT for 7 consecutive years, with -$297000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 92.05% year-over-year to -$297000.0; the trailing twelve-month figure through Jun 2026 stood at -$6.1 million (up 29.34% YoY), and the FY2025 full-year result was -$11.4 million, up 22.18% from the prior year.
• EBT rose to -$297000.0 in Q2 2026 per DERM's latest filing, from -$2.2 million in the prior quarter.
• Across five years, EBT topped out at $16.9 million in Q3 2023 and bottomed at -$10.6 million in Q4 2022.
• Historically, EBT has averaged -$3.4 million across 5 years, with a median of -$2.9 million in 2024.
• The widest YoY moves for EBT: up 267.67% in 2023, down 695.6% in 2023.
• Over 5 years, EBT stood at -$10.6 million in 2022, then surged by 81.02% to -$2.0 million in 2023, then jumped by 178.43% to $1.6 million in 2024, then sank by 178.82% to -$1.2 million in 2025, then soared by 76.18% to -$297000.0 in 2026.
• According to Business Quant data, EBT over the past three periods registered -$297000.0, -$2.2 million, and -$1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.